Asthma Control According to GINA 2023 : Does Changing the Criteria Improve Asthma Control?
Arismendi, Ebymar (Hospital Clínic i Provincial de Barcelona)
Ribó González, Paula (Hospital Clínic i Provincial de Barcelona)
García, A. (Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES))
Torrego, Alfons (Institut de Recerca Sant Pau)
Bobolea, Irina (Hospital Clínic i Provincial de Barcelona)
Casas-Saucedo, R. (Hospital General de Granollers)
Palomino, R. (Pharmalex GmbH)
Picado, César (Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES))
Muñoz-Cano, Rosa (Hospital Clínic i Provincial de Barcelona)
Valero, A. (Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES))
Universitat Autònoma de Barcelona

Date:	2024
Abstract:	Achieving disease control is the main goal in asthmatic patients in order to prevent future risks and exacerbations. There are several clinical guidelines that set different definitions of asthma control, and these differences may affect management and treatment in many patients. Our aim was to describe asthma control patterns according to the Global Initiative for Asthma (GINA) 2023 in patients considered to have uncontrolled asthma as per previous GINA 2010 guidelines. A total of 1299 patients from the COAS study were analyzed. The COAS study was a cross-sectional multicenter study conducted in routine clinical practice that included patients with uncontrolled asthma according to GINA 2010. These patients were then re-classified using the now updated GINA 2023 asthma control criteria. After applying GINA 2023 control criteria, previously uncontrolled patients were now classified as having controlled asthma in 24. 3% of cases and partially controlled asthma in 16. 3% of cases. Only 59. 4% maintained their previous diagnosis of uncontrolled asthma. ACT in the uncontrolled patients remained similar after re-classification, as did the percentage of active smokers, respiratory allergy, rhinitis, and lung function. Changes in clinical guideline criteria affect the definition of asthma control. When excluding pulmonary function abnormalities in GINA 2023 asthma control criteria, the percentage of controlled patients greatly increased.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	ACT ; GINA ; Associated factors ; Asthma ; Clinical characteristics ; Control
Published in:	Journal of clinical medicine, Vol. 13 Núm. 22 (november 2024) , p. 6646, ISSN 2077-0383

DOI: 10.3390/jcm13226646
PMID: 39597790

8 p, 517.7 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles